Marimed (MRMD) Revenue (2011 - 2026)

Marimed (MRMD) has reported Revenue for 16 consecutive years, with $41.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 6.12% year-over-year to $41.9 million in Q2 2026; TTM through Jun 2026 was $163.8 million, a 4.37% increase from a year earlier, with the FY2025 full-year figure at $159.8 million, up 1.34% from the prior year.
• Revenue was $41.9 million for Q2 2026 at Marimed, up from $39.5 million in the prior quarter.
• Over five years, Revenue peaked at $41.9 million in Q2 2026 and troughed at $31.3 million in Q1 2022.
• A 5-year average of $37.9 million and a median of $38.8 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue grew 26.94% in 2022 and decreased 2.3% in 2025, its largest moves.
• Over 5 years, Revenue stood at $35.8 million in 2022, then rose by 8.57% to $38.9 million in 2023, then grew by 0.13% to $38.9 million in 2024, then advanced by 6.93% to $41.6 million in 2025, then rose by 0.66% to $41.9 million in 2026.
• The last three Revenue figures came in at $41.9 million (Q2 2026), $39.5 million (Q1 2026), and $41.6 million (Q4 2025), per Business Quant data.